Current Drug Discovery Technologies
Volume 18, 6 Issues, 2021
ISSN: 1875-6220 (Online)
ISSN: 1570-1638 (Print)
This journal supports open access
ISSN: 1875-6220 (Online)
ISSN: 1570-1638 (Print)
This journal supports open access
In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research
Reviewer Panel
 |
D. Sil University of Nebraska Medical Center Omaha, NE USA Biography Biography of D. Sil
I am Diptesh Sil working as a Postdoctoral Research Associate at Buffet Cancer Center at University of Nebraska Medical Center, Omaha, Nebraska, USA in the department of pharmaceutical sciences under Prof. David Oupicky. My research area is to carry out design, characterization and synthesis of prodrugs of polyamines using different biodegradable linkers and polymers for efficient drug delivery of siRNA and micro RNA for treatment of different types of tumors. Previously, I worked as a Joint Manager in pharmaceuticals and intermediates division (R&D) at Atul Ltd., Valsad, Gujarat, India for more than four years. I was involved in the process development of important chemical intermediates. I obtained my Ph.D. from Central Drug Research Institute (CDRI), Lucknow, India under the supervision of Dr. Vishnu Ji Ram, Ex. Emeritus Scientist, Medicinal and Process Chemistry Division, CDRI. As recognition of my work, I have twenty-eight publications in peer reviewed journals including a book chapter and a US patent.
|
Editor-in-Chief
Vladimir P. Torchilin
(68301 citations)
Department of Pharmaceutical Science Center for Pharmaceutical Biotechnology and Nanomedicine
Northeastern University
Boston, MA 02115
USA
Biography
(68301 citations)
Department of Pharmaceutical Science Center for Pharmaceutical Biotechnology and Nanomedicine
Northeastern University
Boston, MA 02115
USA
Biography
Biography of Vladimir P. Torchilin
Vladimir P. Torchilin, Ph.D., D.Sc. is a University Distinguished Professor of Pharmaceutical Sciences and Director, Center for Pharmaceutical Biotechnology and Nanomedicine, Northeastern University, Boston. His interests include drug delivery and targeting, nanomedicine, multifunctional and stimuli-sensitive pharmaceutical nanocarriers, biomedical polymers, experimental cancer therapy. He has published more than 400 original papers, more than 150 reviews and book chapters, wrote and edited 12 books, and holds more than 40 patents. Google Scholar shows more than 44,000 citations of his papers with H-index of 96. He is Editor-in-Chief of Current Drug Discovery Technologies, Drug Delivery, and OpenNano, Co-Editor of Current Pharmaceutical Biotechnology and on the Editorial Boards of many other journals. He received more than $30 M from the governmental and industrial sources in research funding. He has multiple honors and awards and in 2011, Times Higher Education ranked him number 2 among top world scientists in pharmacology for the period of 2000-2010.
COPE Compliant
About the Journal
For Authors
For Librarians & Readers
Quick Links
Journal History
Current Drug Discovery Technologies Journal was launched in 2004. Dr. Vladimir P. Torchilin serves as the Editor-in-Chief of the journal.
Scopus CiteScore Metrics: 1.42
New eBook
 |
Frontiers in Clinical Drug Research – Alzheimer DisordersYou can view the contents of this eBook [here] or purchase it [here]. |
Advertisement
Webmaster Contact: info@benthamscience.net